To sum up, accumulating evidence supports the prognostic and predictive impact of different subpopulations of CD8(+) T cells, including proliferating CD8(+)TCF1(+) T cells, as well as subpopulations of CD4(+) T cells and TAMs in invasive breast carcinoma. The gene discussed is CD8A; the disease is invasive breast carcinoma.